Ready to cut time to save lives? Request consultation
Future-proof Healthcare
CEO Jonas Jarvius explains how Q-linea is intimately tied to his experiences of healthcare inequity, and how Q-linea is working to ensure we have sustainable and equitable healthcare, now and in the future.
“A huge advantage”
Listen to Ehsan Ghaderi, Head of Department, and Sofia Persson, Consultant Physician, Bacteriology Uppsala University Hospital, talks about how ASTar have helped save time in the lab.
“You will be much faster in adjusting the treatment”
Listen to Martin Sundqvist, Senior consultant, PhD, Clinical Microbiology, Örebro University Hospital. President of the Swedish Society of Clinical Microbiology speak about the value of rapid AST, true MIC values and more.
Find more words about us here
News & events
Q-linea strengthens management team
Q-linea participates in comparative rapid AST study
Q-linea is offered a loan facility of SEK 100 million from main owner Nexttobe
Q-linea AB (publ) (OMX: QLINEA) today announces that the company’s main owner Nexttobe is offering the company SEK 100…
Read more >
Q-linea as an investment
Q-linea is an innovative infection diagnostics company whose ambition is to offer products that benefit patients, healthcare providers and society.
Get in touch
We are happy to help. Please contact us with any questions or queries, we are just a click away.Q-linea as an investment
Q-linea is an innovative infection diagnostics company whose ambition is to offer products that benefit patients, healthcare providers and society.
Get in touch
We are happy to help. Please contact us with any questions or queries, we are just a click away.